Clinical studies in head and neck cancer chemoprevention

Cancer and Metastasis Reviews

Volumn 15, Issue 1, 1996, Pages 113-118

  Gonzalez, Pablo M ^a,b   Benner, Steven E ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

cancer; chemoprevention; head and neck; retinoids; secondary neoplasms

Indexed keywords

ALPHA TOCOPHEROL; ALPHA TOCOPHEROL DERIVATIVE; AROTINOID; BETA CAROTENE; CAROTENOID; FENRETINIDE; ISOTRETINOIN; RETINOID; SELENIUM;

CHEMOPROPHYLAXIS; CLINICAL TRIAL; HEAD AND NECK CANCER; HUMAN; LEUKOPLAKIA; METASTASIS; PRIORITY JOURNAL; REVIEW;

ANTICARCINOGENIC AGENTS; CLINICAL TRIALS; HEAD AND NECK NEOPLASMS; HUMANS; RETINOIDS;

EID: 0029934993     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00049490     Document Type: Review

References (35)

1. Vokes EE, Weichselbaum RR, Lippman SM, Hong WK: Head and neck cancer. N Engl J Med 328: 184-194, 1993
2. Slaughter DP, Southwick HW, Smejkal W: 'Field cancerization' in oral stratified squamous epithelium: clinical implications of multicentric origin. Cancer 6: 963-968, 1953
3. Conn AM, Peppard SB: Multiple primary malignant tumors of the head and neck. Am J Otolaryngol 1: 411-417, 1980
4. Johnson NW, Ranasinghe AW, Warnakulasuriya: Potentially malignant lesions and conditions of the mouth and oropharynx: natural history-cellular and molecular markers of risk. Eur J Cancer Prev 2: 31-51, 1993
5. Silverman S Jr, Gorsky M, Lozada F: Oral leukoplakia and malignant transformation. Cancer Res 52: 2758-2763, 1992
6. Bouquot JE, Gorlin RJ: Leukoplakia, lichen planus and other oral keratoses in 23616 white Americans over the age of 35 years. Oral Surg 61: 373-381, 1986
7. Daftari DK, Murti PR, Bhonsle RB, Gupta PC, Metha FS, Pindhorg JJ: Oral precancerous lesions and conditions of tropical interest. In: Prabhu SR, Wilson DF, Daftari DK, Johnson NW (eds) Oral Diseases in the Tropics. Oxford Medical Publications, Oxford, 1992, pp 402-428
8. Shafer WG, Waldron CA: Erythroplakia of the oral cavity. Cancer 36: 1021-1028, 1975
9. Lippman SM, Hong WK: Second malignant tumors in head and neck squamous cell carcinoma: the overshadowing threat for patients with early stage disease. Int J Radiat Oncol Biol Phys 17: 691-694, 1989
10. Lotan R, Xu XC, Lippman SM, Ro JY, Lee JS, Lee JJ, Hong WK: Suppression of retinoic acid receptor-beta in premalignant oral lesions and its up-regulation by isotretinoin. N Engl J Med 322: 1405-1410, 1995
11. Silverman S, Renstrup G, Pindborg JJ: Studies in oral leukoplakia. Acta Odontol Scan 21: 271-292, 1963
12. Silverman S, Eisenberg E, Renstrup G: A study of the effects of vitamin A on oral leukoplakia (hyperkeratosis), including toxicity, liver function and skeletal metabolism. J Oral Ther Pharrnacol 2: 9-23, 1965
13. Raque CJ, Biondo RV, Keeran MG, Honeycutt WM, Jansen GT: Snuff dippers keratosis (Snuff induced leukoplakia). South Med J 68: 565-568, 1975
14. Koch HF: Biochemical treatment of precancerous oral lesions: The effectiveness of various analogues of retinoic acid. J Max Fat Surg 6: 59-63, 1978
15. Koch HF: Effects of retinoids on precancerous lesions of oral mucosa. In: Orfanos CE, Braun-Falco O, Farber EM, Gruper Ch, Polano MK, Schuppli R (eds) Retinoids. Advances in Basic Research and Therapy. Springer-Verlag, Berlin, Heidelberg, New York, 1981, pp 307-312
16. Hong WK, Endicott J, Itri LM, Doos W, Batsakis JG, Bell R, Fofonoff S, Byers R, Atkinson EN, Vaughan C, Toth BB, Kramer A, Dimery IW, Skipper P, Strong S: 13-cis-retinoic acid in the treatment of oral leukoplakia. N Engl J Med 315: 1501-1505, 1986
17. Toma S, Mangiante PE, Margarino G, Nicolo G, Palumbo R: Progressive 13-cis-retinoic acid dosage in the treatment of oral leukoplakia. Oral Oncol Eur J Cancer 28B: 121-123, 1992
18. Shekelle RB, Lepper M, Liu S, et al.: Dietary vitamin A and risk of cancer in the Western Electric Study. Lancet 2: 1185-1190, 1981
19. Garewall ER, Meyskens FL Jr, Kellen D, Reeves D, Kiersch TA., Elletson H, Stosberg A, King D, Steinbronn: Responses of oral leukoplakia to β-carotene. J Clin Oncol 8: 1715-1720, 1990
20. Toma S, Albanese L, Delorenzi M, et al.: β-carotene in the treatment of oral leukoplakia. (Abstract) Proc Am Soc Clin Oncol 9: 179, 1990
21. Malaker K, Anderson B, Beecroft W, Hodson D: Management of oral mucosal dysplasia with β-carotene and retinoic acid: a pilot cross-over study. Cancer Detect Prev 15: 335-340, 1991
22. Lippman SM, Batsakis JG, Toth BB, Weber RS, Lee JJ, Martin JW, Hays GL, Goepfert H, Hong WK: Comparison of low-dose isotretinoin with carotene to prevent oral carcinogenesis. N Engl J Med 328: 15-20, 1993
23. Chiesa F, Tradati N, Marazza M, Rossi N, Boracchi P, Mariani L, Clerici M, Formelli F, Barzan L, Carrasi A, Pastorini A, Camerini T, Giardini R, Zurrida S, Minn FL, Costa A, De Palo G, Veronesi U: Prevention of local relapses and new localisations of oral leukoplakia with the synthetic retinoid fenretidine (4-HPR). Preliminary results. Oral Oncol Eur J Cancer 28B: 97-102, 1992
24. Besa EC, Abrahm JL, Bartholomew MJ, Hysinski M, Nowell PC: Treatment with 13-cis-retinoic acid in transfusion-dependent patients with myelodysplastic syndrome and decreased toxicity with the addition of α-tocopherol. Am J Med 89: 739-747, 1990
25. Dimery I, Shirinian M, Heyne K, Lippman SM, Fritsche H, Guillary C, Fossella S, Shin D, Hong WK: Reduction in toxicity of high dose 13-cis-retinoic acid (13-cRA) with α-tocopherol (AT). (Abstract) Proc Am Soc Clin Oncol 11: 399, 1992
26. Benner SE, Winn RJ, Lippman SM, Poland J, Hansen KS, Luna MA, Hong WK: Regression of oral leukoplakia with α-tocopherol: A community clinical oncology program chemoprevention study. J Natl Cancer Inst 85: 44-47, 1993
27. Shamberger RJ, Rukovena E, Lonfield AK, Tytko SA, Deodhar S, Willis CE: Antioxidants and cancer. I. Selenium in the blood of normal and cancer patients. J Natl Cancer Inst 4: 4863-4870, 1973
28. Temple NJ, Basu TK: Selenium and cabbage and colon carcinogenesis in mice. J Natl Cancer Inst 5: 1131-1134, 1987
29. Toma S, Michcletti A, Giachero A, Coialbu T, Collechi P, Esposito M, Rotondi M, Albanese E, Cantoni E: Selenium therapy in patients with precancerous and malignant oral cavity lesions: Preliminary results. Cancer Prev Detect 15: 491-494, 1991
30. Hong WK, Lippman SM, Itri LM, Karp DD, Lee JS, Byers RM, Schantz SP, Kramer AM, Lotan R, Peters LJ, Dimery IW, Brown BW, Goepfert H: Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med 323: 795-801, 1990
31. Benner SH, Pajak TF, Lippman SM, Early C, Hong WK: Prevention of second primary tumors with isotretinoin in patients with squamous cell carcinoma of the head and neck: Long-term follow-up. J Natl Cancer Inst 86: 140-141, 1994
32. Bolla M, Lefur R, Ton Van J, Domenge C, Badet JM, Koskas Y, Laplanche A: Prevention of second primary tumours with etretinate in squamous cell carcinoma of the oral cavity and oropharynx. Results of a multicentric double-blind randomised study. Eur J Cancer 30A: 767-772, 1994
33. Pastorino U, Infante M, Maioli M, Chiesa G, Buyse M, Firket P, Rosmentz N, Clerici M, Soresi E, Valente M, Bellone PA, Ravasi G: Adjuvant treatment of stage 1 lung cancer with high-dose vitamin A. J Clin Oncol 11: 1216-1222, 1993
34. Van Zandwijk N, Pastorino U, De Vries N, Dalesio O: Huroscan: the European Organization for Research and Treatment of Cancer (EORTC): Chemoprevention study in lung cancer. Lung Cancer 9: 351-356, 1993
35. Pastorino U, Van Zandwijk N, De Vries N, Dalesio O, Van Tinteren H: Results of the Euroscan trial. Proc Seventh World Conference on Lung Cancer. Lung Cancer 11: 94-95, 1994